spacer
spacer

PDBsum entry 1gjh

Go to PDB code: 
Top Page protein links
Apoptosis PDB id
1gjh
Contents
Protein chain
164 a.a. *
* Residue conservation analysis

References listed in PDB file
Key reference
Title Solution structure of the antiapoptotic protein bcl-2.
Authors A.M.Petros, A.Medek, D.G.Nettesheim, D.H.Kim, H.S.Yoon, K.Swift, E.D.Matayoshi, T.Oltersdorf, S.W.Fesik.
Ref. Proc Natl Acad Sci U S A, 2001, 98, 3012-3017. [DOI no: 10.1073/pnas.041619798]
PubMed id 11248023
Abstract
The structures of two isoforms of Bcl-2 that differ by two amino acids have been determined by NMR spectroscopy. Because wild-type Bcl-2 behaved poorly in solution, the structures were determined by using Bcl-2/Bcl-x(L) chimeras in which part of the putative unstructured loop of Bcl-2 was replaced with a shortened loop from Bcl-x(L). These chimeric proteins have a low pI compared with the wild-type protein and are soluble. The structures of the two Bcl-2 isoforms consist of 6 alpha-helices with a hydrophobic groove on the surface similar to that observed for the homologous protein, Bcl-x(L). Comparison of the Bcl-2 structures to that of Bcl-x(L) shows that although the overall fold is the same, there are differences in the structural topology and electrostatic potential of the binding groove. Although the structures of the two isoforms of Bcl-2 are virtually identical, differences were observed in the ability of the proteins to bind to a 25-residue peptide from the proapoptotic Bad protein and a 16-residue peptide from the proapoptotic Bak protein. These results suggest that there are subtle differences in the hydrophobic binding groove in Bcl-2 that may translate into differences in antiapoptotic activity for the two isoforms.
Figure 1.
Fig. 1. Sequence alignment of full-length Bcl-x[L], the three isoforms of full-length Bcl-2 [denoted Bcl-2(1) (1,2), Bcl-2(2) (3,4), and Bcl-2(3) (5,6)], and the truncated Bcl-2/Bcl-x[L] chimeras used in this study. Amino acid differences between the Bcl-2 isoforms are shown in red, the truncated loop is shown in green, and the putative membrane-spanning region is shown in blue. -helices previously identified in Bcl-x[L] are denoted above the sequence in red.
Figure 3.
Fig. 3. Solvent-accessible surface showing hydrophobic groove for Bcl-2(1) (A) and Bcl-2(2) (B). Leucine, isoleucine, valine, tyrosine, phenylalanine, and tryptophan residues are colored yellow, aspartate and glutamate are colored red, and lysine, arginine, and histidine are colored blue. All other residue types are colored gray.
Secondary reference #1
Title Cloning and structural analysis of cdnas for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation.
Authors M.L.Cleary, S.D.Smith, J.Sklar.
Ref. Cell, 1986, 47, 19-28. [DOI no: 10.1016/0092-8674(86)90362-4]
PubMed id 2875799
Full text Abstract
Secondary reference #2
Title Alternative promoters and exons, Somatic mutation and deregulation of the bcl-2-Ig fusion gene in lymphoma.
Authors M.Seto, U.Jaeger, R.D.Hockett, W.Graninger, S.Bennett, P.Goldman, S.J.Korsmeyer.
Ref. Embo J, 1988, 7, 123-131.
PubMed id 2834197
Abstract
PROCHECK
Go to PROCHECK summary
 Headers

 

spacer

spacer